Tonix Pharmaceuticals Holding (TNXP) Cash & Equivalents (2023 - 2025)
Historic Cash & Equivalents for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $190.1 million.
- Tonix Pharmaceuticals Holding's Cash & Equivalents rose 57316.62% to $190.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.1 million, marking a year-over-year increase of 57316.62%. This contributed to the annual value of $98.8 million for FY2024, which is 29592.75% up from last year.
- As of Q3 2025, Tonix Pharmaceuticals Holding's Cash & Equivalents stood at $190.1 million, which was up 57316.62% from $125.3 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Cash & Equivalents ranged from a high of $190.1 million in Q3 2025 and a low of $4.2 million during Q2 2024
- Moreover, its 3-year median value for Cash & Equivalents was $28.2 million (2024), whereas its average is $65.0 million.
- Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9020.63% in 2024, then skyrocketed by 291566.41% in 2025.
- Tonix Pharmaceuticals Holding's Cash & Equivalents (Quarter) stood at $24.9 million in 2023, then skyrocketed by 295.93% to $98.8 million in 2024, then surged by 92.41% to $190.1 million in 2025.
- Its Cash & Equivalents was $190.1 million in Q3 2025, compared to $125.3 million in Q2 2025 and $131.7 million in Q1 2025.